US IVF CLINICS MAY BE OVER-SERVICING
American IVF clinics may be overusing a technique for fertilising patients’ eggs to create embryos, costing couples and some insurers hundreds of extra dollars. , the technique, intracytoplasmic sperm injection (ICSI) was originally developed to help men with defective sperm or low sperm counts by injecting a single sperm into an egg. However, many clinics are now using it for other infertile couples.
“This paper is particularly troubling because we’ve got a major shift in practice that isn’t evidence driven,” says bioethicist Arthur Caplan, of the University of Pennsylvania. “The paper suggests that it may be driven by money.” The research team reviewed a decade of IVF and found that ICSI treatments had risen from 11% in 1995 to 58% in 2004. However, the incidence of male infertility had remained the same, at about 34%. Not only does the technique cost about US$1,500 more, but it is not quite as effective as standard IVF.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...